Acknowledgement
We are grateful to Prof. Oh-kyeong Kweon (Seoul National University) for providing the cADSCs.
References
- Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C. Adipose-derived stem cells: isolation, expansion and differentiation. Methods. 2008;45(2):115-120. https://doi.org/10.1016/j.ymeth.2008.03.006
- Schwarz C, Leicht U, Rothe C, Drosse I, Luibl V, Rocken M, et al. Effects of different media on proliferation and differentiation capacity of canine, equine and porcine adipose derived stem cells. Res Vet Sci. 2012;93(1):457-462. https://doi.org/10.1016/j.rvsc.2011.08.010
- Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211-228. https://doi.org/10.1089/107632701300062859
- Jankowski M, Dompe C, Sibiak R, Wasiatycz G, Mozdziak P, Jaskowski JM, et al. In vitro cultures of adipose-derived stem cells: an overview of methods, molecular analyses, and clinical applications. Cells. 2020;9(8):1783. https://doi.org/10.3390/cells9081783
- Kingham PJ, Kolar MK, Novikova LN, Novikov LN, Wiberg M. Stimulating the neurotrophic and angiogenic properties of human adipose-derived stem cells enhances nerve repair. Stem Cells Dev. 2014;23(7):741-754. https://doi.org/10.1089/scd.2013.0396
- Ma T, Sun J, Zhao Z, Lei W, Chen Y, Wang X, et al. A brief review: adipose-derived stem cells and their therapeutic potential in cardiovascular diseases. Stem Cell Res Ther. 2017;8(1):124. https://doi.org/10.1186/s13287-017-0585-3
- Hong W, Park J, Yun W, Kang PJ, Son D, Jang J, et al. Inhibitory effect of celastrol on adipogenic differentiation of human adipose-derived stem cells. Biochem Biophys Res Commun. 2018;507(1-4):236-241. https://doi.org/10.1016/j.bbrc.2018.11.014
- Dieudonne MN, Pecquery R, Leneveu MC, Giudicelli Y. Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor γ2. Endocrinology. 2000;141(2):649-656. https://doi.org/10.1210/en.141.2.649
- Farmer SR. Transcriptional control of adipocyte formation. Cell Metab. 2006;4(4):263-273. https://doi.org/10.1016/j.cmet.2006.07.001
- Scott MA, Nguyen VT, Levi B, James AW. Current methods of adipogenic differentiation of mesenchymal stem cells. Stem Cells Dev. 2011;20(10):1793-1804. https://doi.org/10.1089/scd.2011.0040
- Fayyad AM, Khan AA, Abdallah SH, Alomran SS, Bajou K, Khattak MNK. Rosiglitazone enhances browning adipocytes in association with MAPK and PI3-K pathways during the differentiation of telomerase-transformed mesenchymal stromal cells into adipocytes. Int J Mol Sci. 2019;20(7):1618. https://doi.org/10.3390/ijms20071618
- Foryst-Ludwig A, Kintscher U. Metabolic impact of estrogen signalling through ERalpha and ERbeta. J Steroid Biochem Mol Biol. 2010;122(1-3):74-81. https://doi.org/10.1016/j.jsbmb.2010.06.012
- Jeong S, Yoon M. 17β-Estradiol inhibition of PPARγ-induced adipogenesis and adipocyte-specific gene expression. Acta Pharmacol Sin. 2011;32(2):230-238. https://doi.org/10.1038/aps.2010.198
- Dieudonne MN, Leneveu MC, Giudicelli Y, Pecquery R. Evidence for functional estrogen receptors alpha and beta in human adipose cells: regional specificities and regulation by estrogens. Am J Physiol Cell Physiol. 2004;286(3):C655-C661. https://doi.org/10.1152/ajpcell.00321.2003
- Hong L, Colpan A, Peptan IA, Daw J, George A, Evans CA. 17-β estradiol enhances osteogenic and adipogenic differentiation of human adipose-derived stromal cells. Tissue Eng. 2007;13(6):1197-1203. https://doi.org/10.1089/ten.2006.0317
- Stubbins RE, Holcomb VB, Hong J, Nunez NP. Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance. Eur J Nutr. 2012;51(7):861-870. https://doi.org/10.1007/s00394-011-0266-4
- Kopelman PG. Obesity as a medical problem. Nature. 2000;404(6778):635-643. https://doi.org/10.1038/35007508
- German AJ. The growing problem of obesity in dogs and cats. J Nutr. 2006;136(7 Suppl):1940S-1946S. https://doi.org/10.1093/jn/136.7.1940S
- Ryu HH, Kang BJ, Park SS, Kim Y, Sung GJ, Woo HM, et al. Comparison of mesenchymal stem cells derived from fat, bone marrow, Wharton's jelly, and umbilical cord blood for treating spinal cord injuries in dogs. J Vet Med Sci. 2012;74(12):1617-1630. https://doi.org/10.1292/jvms.12-0065
- Ryu HH, Lim JH, Byeon YE, Park JR, Seo MS, Lee YW, et al. Functional recovery and neural differentiation after transplantation of allogenic adipose-derived stem cells in a canine model of acute spinal cord injury. J Vet Sci. 2009;10(4):273-284. https://doi.org/10.4142/jvs.2009.10.4.273
- Tobita M, Orbay H, Mizuno H. Adipose-derived stem cells: current findings and future perspectives. Discov Med. 2011;11(57):160-170.
- Animal and Plant Quarantine Agency. 2017 Animal Protection and Welfare Survey. Gimcheon: Animal and Plant Quarantine Agency; 2017.
- Saben J, Thakali KM, Lindsey FE, Zhong Y, Badger TM, Andres A, et al. Distinct adipogenic differentiation phenotypes of human umbilical cord mesenchymal cells dependent on adipogenic conditions. Exp Biol Med (Maywood). 2014;239(10):1340-1351. https://doi.org/10.1177/1535370214539225
- Lu YH, Dallner OS, Birsoy K, Fayzikhodjaeva G, Friedman JM. Nuclear Factor-Y is an adipogenic factor that regulates leptin gene expression. Mol Metab. 2015;4(5):392-405. https://doi.org/10.1016/j.molmet.2015.02.002
- Yu G, Floyd ZE, Wu X, Hebert T, Halvorsen YD, Buehrer BM, et al. Adipogenic differentiation of adipose-derived stem cells. Methods Mol Biol. 2011;702:193-200. https://doi.org/10.1007/978-1-61737-960-4_14
- Lala-Tabbert N, Fu D, Wiper-Bergeron N. Induction of CCAAT/enhancer-binding protein β expression with the phosphodiesterase inhibitor isobutylmethylxanthine improves myoblast engraftment into dystrophic muscle. Stem Cells Transl Med. 2016;5(4):500-510. https://doi.org/10.5966/sctm.2015-0169
- Kim SP, Ha JM, Yun SJ, Kim EK, Chung SW, Hong KW, et al. Transcriptional activation of peroxisome proliferator-activated receptor-γ requires activation of both protein kinase A and Akt during adipocyte differentiation. Biochem Biophys Res Commun. 2010;399(1):55-59. https://doi.org/10.1016/j.bbrc.2010.07.038
- Madsen MS, Siersbaek R, Boergesen M, Nielsen R, Mandrup S. Peroxisome proliferator-activated receptor γ and C/EBPα synergistically activate key metabolic adipocyte genes by assisted loading. Mol Cell Biol. 2014;34(6):939-954. https://doi.org/10.1128/MCB.01344-13
- Contador D, Ezquer F, Espinosa M, Arango-Rodriguez M, Puebla C, Sobrevia L, et al. Dexamethasone and rosiglitazone are sufficient and necessary for producing functional adipocytes from mesenchymal stem cells. Exp Biol Med (Maywood). 2015;240(9):1235-1246. https://doi.org/10.1177/1535370214566565
- Rosen ED, Spiegelman BM. PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem. 2001;276(41):37731-37734. https://doi.org/10.1074/jbc.R100034200
- Berger JP, Akiyama TE, Meinke PT. PPARs: therapeutic targets for metabolic disease. Trends Pharmacol Sci. 2005;26(5):244-251. https://doi.org/10.1016/j.tips.2005.03.003
- Farmer SR. Regulation of PPARγ activity during adipogenesis. Int J Obes. 2005;29 Suppl 1:S13-S16. https://doi.org/10.1038/sj.ijo.0802907
- Leesnitzer LM, Parks DJ, Bledsoe RK, Cobb JE, Collins JL, Consler TG, et al. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry. 2002;41(21):6640-6650. https://doi.org/10.1021/bi0159581
- Seargent JM, Yates EA, Gill JH. GW9662, a potent antagonist of PPARγ, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARγ agonist rosiglitazone, independently of PPARγ activation. Br J Pharmacol. 2004;143(8):933-937. https://doi.org/10.1038/sj.bjp.0705973
- Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-α knockout mice. Proc Natl Acad Sci U S A. 2000;97(23):12729-12734. https://doi.org/10.1073/pnas.97.23.12729
- Tao Z, Zheng LD, Smith C, Luo J, Robinson A, Almeida FA, et al. Estradiol signaling mediates gender difference in visceral adiposity via autophagy. Cell Death Dis. 2018;9(3):309. https://doi.org/10.1038/s41419-018-0372-9
- Wada T, Ihunnah CA, Gao J, Chai X, Zeng S, Philips BJ, et al. Estrogen sulfotransferase inhibits adipocyte differentiation. Mol Endocrinol. 2011;25(9):1612-1623. https://doi.org/10.1210/me.2011-1089
- Hong L, Colpan A, Peptan IA. Modulations of 17-β estradiol on osteogenic and adipogenic differentiations of human mesenchymal stem cells. Tissue Eng. 2006;12(10):2747-2753. https://doi.org/10.1089/ten.2006.12.2747
- Pedersen SB, Kristensen K, Hermann PA, Katzenellenbogen JA, Richelsen B. Estrogen controls lipolysis by up-regulating α2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor α. Implications for the female fat distribution. J Clin Endocrinol Metab. 2004;89(4):1869-1878. https://doi.org/10.1210/jc.2003-031327
- Wang X, Kilgore MW. Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells. Mol Cell Endocrinol. 2002;194(1-2):123-133. https://doi.org/10.1016/S0303-7207(02)00154-5
- Surazynski A, Jarzabek K, Miltyk W, Wolczynski S, Palka J. Estrogen-dependent regulation of PPAR-gamma signaling on collagen biosynthesis in adenocarcinoma endometrial cells. Neoplasma. 2009;56(5):448-454. https://doi.org/10.4149/neo_2009_05_448
- Boucher JG, Ahmed S, Atlas E. Bisphenol S induces adipogenesis in primary human preadipocytes from female donors. Endocrinology. 2016;157(4):1397-1407. https://doi.org/10.1210/en.2015-1872